Professional Documents
Culture Documents
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
Drug in Dentistry
• Giving drug is very common in dentistry
• Allowed according to the Dental Act
Drugs in Oral Medicine • Must know what are :
– Indication of giving drug
– Age of patient
mms omop
omop//usim/3/11
usim/3/11 – Medical and drug history
– Allergies
– Contraindication and side effect
• Required by law to know all the information
above before giving drug
1
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
General Rules
Writing Prescriptions
Rx: Drug Name (can be generic) Unit Dose • Write Legibly!!
(ex: Pen V
V--K 500 mg, Elixer, Sol’n) • Remember your audience (Generally non-
non-
docs) this will improve compliance.
Disp: # of pills, milliliters (ml), mg
• Preferable to order specific hourly dosage time
Directions for use: od, bds, qid, prn pain, till gone; topical, (q12h vs. bid, q8h vs. tid, etc.)
oral
• Specify # of pills to take each dose
Refills__ Signature • Prescribe an endpoint. (prn pain, till gone)
Prescribing Prescribing
• Must write : • Hospital/ward drug
– Patient’s name – Special form and request, see hospital protocol
– Name of drug • Children and elderly must altered dose
according to the drug information sheet
– Date given
– Dosage
• Ignorance “tak tahu/ don’t remember” is not
• Must write clearly and given appropriate applicable in court. As a doctor you must know.
advise on taking the medication eg. • Sleep with drug formulary rather than sleep with
Oral,topical, PA etc other things
• Antibiotics
– Organic substances produced by
Antibiotic Use In Dentistry microorganisms that have the ability to
destroy or inhibit the growth of bacteria
and other microorganisms.
2
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
Considerations
Discussion: Antibiotic Choice
• Gram Positive?
• Gram Negative?
• Narrow Spectrum?
• Mixed Infection?
• Extended/Broad Spectrum?
• Anaerobes?
• Designer Antibiotics?
• Anaerobes? Consider if the infection is
present > 3days or if no improvement.
3
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
• Specific for the pathogen. • Affects both Gram + and Gram – bacteria,
• Fewer disturbances of non-
non-pathogenic better for mixed infections.
bacteria. • May give up some effectiveness for Gram
• Fewer side effects. + to gain effectiveness for Gram -.
• Rapid response for sensitive organisms. • Examples: Amoxicillin, Ampicillin
• Ex: Pen VK, Pen G, Erythromycin
Common Pathogens
Common Pathogens
•Necrotic pulp and apical abscesses • Periodontal Diseases
–Obligate anaerobic bacteria
•Gram negative rods Gingivitis
–Prevotella & porphyomonas spp. Fuso, strep, & actinomycetes
–Fusobacterium spp.
–Campylobacter rectus Adult periodontitis
•Gram positive rods – Bacteroides, porphyomonas,
–Eubacterium spp.
–Actinomycetes spp. peptostreptococcus & prevotella
•Gram positive cocci Acute necrotizing ulcerative gingivitis
–Peptostreptococcus spp.
Spirochetes, prevotella, fuso
–Facultative anaerobic bacteria
•Gram positive cocci – Localized juvenile periodontitis
–Strep and Entercoccus spp. Actinobacillus
About Resistance
Common Pathogens
• Three main types
– Chromosome mediated
• Spontaneous mutations
• Fungal Infections • Non-major form of drug resistance
• Rarely lead to complete resistance
Candida spp. – Plasmid mediated (conjugation)
Mucorales spp. • VERY important from clinical standpoint
• Mostly gram negs
• Mediate resistance to multiple drugs
• High transfer rate from cell to cell
– Transposon (transduction and transformation)
• Phage mediated
• Clinically important for Gram +
4
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
ß-Lactams
• Natural penicillins
Antibiotic Choices – Pen VK and Pen G
• MOA: Inhibit cell wall synthesis
• Dose: 250-500 mg qid x 7-10 days
• Contraindications:
– Allergies
– Poor renal fxn
• Adverse events: GI upset
• Drug interactions: oral contraceptives
ß-Lactams ß-Lactams
• Natural penicillins • Amino-penicillins
– Pen VK and Pen G – Amoxicillin, ampicillin
• Bactericidal • MOA: Inhibit cell wall synthesis
• Allergic reaction: rare (4 per 100,000) • Dose: 250-500 mg q 8 h x 7-10 days
• Contraindications:
• Spectrum: – Allergies
– Strep, staph, enterococcus, neiseria, treponema, listeria – Poor renal fxn
• Resistance: • Adverse events: GI upset
– Mostly staph (>80%) • Drug interactions: oral contraceptives
• Amoxicillin and clavulanic acid (Augmentin)
ß-Lactams Cephalosporins
• Amino-penicillins • Cephalexin (Keflex)
– Amoxicillin, ampicillin – MOA: Inhibit cell wall synthesis
• Bactericidal – Dose: 250-1000mg q 6 h x 7-10 days
• “ampicillin” rash (4-10%) – Contraindications:
• Spectrum: • Allergies
– Strep, staph, enterococcus, neiseria, treponema, listeria,
E. coli, proteus, H. Flu, shigella, salmonella • Poor renal fxn
• Resistance: – Adverse events: mild GI
– Entero, citro, serratia, proteus vulagris, provedincia, – Drug interactions: probenecid
morganella, pseudomonas aeriginosa, acinetobacter
5
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
Cephalosporins Lincosamides
Lincosamides Macrolides
• Clindamycin • Azithromycin (Zithromax), clarithromycin
– Bactericidal or static depending on (Biaxin)
concentration – MOA: bind to the 23S rRNA in the 50S subunit
ribosome
– Spectrum: – Dose: 250-500 mg/day x 5-10 days
• Gram +, anaerobes, parasites – Precautions :
– Resistance • Poor hepatic fxn
• Enteroccocus – Adverse effects: GI
– Drug interactions: Cytochrome P-450
*Clostridium diff. pseudomembranous colitis!!
Macrolides Tetracyclines
• Azithromycin, clarithromycin • Doxycycline (Vibramycin)
– MOA: inhibit protein synthesis by preventing
– Bactericidal aminoacyl transfer RNA from entering the acceptor
– Spectrum: sites on the ribosome
• Gram +, gram -, anaerobes – Dose: 100mg qd-bid x 7-14 days
– Contraindications:
– Resistance: • pregnancy
• B. fragilis, and strep pneumo – Adverse events: GI
– Drug interactions: anti-epileptics
– Not indicated for Pregnant ladies
6
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
Tetracyclines Nitroimidazoles
• Doxycycline • Metronidazole (Flagyl)
– Bacteriostatic – MOA: reduced intermediate interacts and
– Spectrum: breaks the bacterial or parasitic DNA
• Broad, Gram +, -, anaerobes, aerobes, and – Dose: 250-1000 mg q 6-8 h x 7-10 days
spirochetes – Precautions : poor hepatic fxn
– Resistance: – Drug interactions: warfarin, Li+
• Widespread, cross resistance
– Not indicated for Pregnant ladies
– PHOTO SENSITIVITY!!!
Nitroimidazoles
• Metronidazole
– Bactericidal
– Spectrum:
• Gram - anaerobes Systemic & Topical
– Resistance:
• Rare, H. Pylori?
– Unpleasant metallic taste Some are fungistatic,
while others are fungicidal
7
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
Antifungals Antifungals
• Nystatin • Clotrimazole (Mycelex), ketoconazole
– MOA: inhibit cell wall synthesis (Nizoral), fluconazole (Diflucan)
– Dose: 5 ml swish and swallow q 4 h x 10-14 d – MOA: inhibit cell wall synthesis
– GI upset – Dose: 200-800 mg qd x up to 12 months
– Drug interactions: minor – GI upset
– Drug interactions: major p-450 enzyme
inhibitor, interactions with many drugs
Antiviral
• Acyclovir
acycolvir cream 5% apply to lips 5x daily primary herpetic
gingivostomatitis
herpes labialis
ointment 3% zoster of ophthalmic div
8
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
Sources
• http://www.lamisil.com/
• http://www.journals.uchicago.edu/CID/journal/issues/v3
0n4/990666/990666.text.html?erFrom=-
0n4/990666/990666.text.html?erFrom=-
Statement of Antibiotic
4860378516935905751Guest
• http://www.mycology.adelaide.edu.au/downloads/antifu
Prophylaxis
ngals.pdf#search=%22antifungal%20drugs%22
• http://inventors.about.com/library/inventors/blnystatin.h
tm
9
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
Legal Considerations
AAOS Statement • The dentist may not be aware of the
Antibiotic prophylaxis is NOT patient’s medical condition.
recommended for dental patients • Physician may not be aware of the advisory
with plates, pins, or screws, nor is statements or of the dental procedure to be
it routinely recommended for performed.
MOST dental patients with TOTAL • Vicarious Liability: “The devil made me do
JOINT REPLACEMENTS. it”
• “I forgot to take my antibiotic.”
• Documentation.
Dental Infection
Patient factors
Acute—Rapid growth
• Cost
– Brand name, length of course, alternatives? Allergic to PCN Clindamycin 300mg q8h
10
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
• Hemostatica • Corticosteroids
– Arrest the flow of blood – For inflammatory and immune mediated
conditions
– Not effective against profuse bleeding
– Hydrocortisone is an endogenous agent –
– Three main types used in dentistry cause blood levels to spike during stress
• Gelfoam used at extraction sites
• Surgicel used at extraction sites
• 2x2’s, cotton rolls, retraction cord
11
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
Corticosteroids Corticosteroids
• Systemic
• Topical • Common clinical use:
– Triamcinolone acetonide 0.1%
– Kenalog in Orabase
– RAU
– Hydrocortisone 1% • Aim of treatment is to intercept the development of the
– Betamethasone 0.5 mg ulcerative of the lesion by the broad based
– Beclomethasone spray
immunosuppressive activity
• Intra
Intra--lesional injection • Pt are to apply the agent immediately after the first
– Severe disease and chronic lesions that plateau and not progress to a healing prodromal awareness of a lesion present
phase
– Lip : atrophy & sclerosis – LP
• GC may improve some components of the local tissue lesion
• Common clinical use:
– RAU • The underlying and persistent immune mechanisms remain
– LP active
Corticosteroids Corticosteroids
- adverse reaction
• GC do not have an effect on the primary
disease mechanism • Secondary condidosis
• Nausea
• It minimize both disease activity and • Refractory response
clinical morbidity – Poor compliance
– Inappropriate instruction
• May also plat a role in the development of – Inappropriate application
– Incorrect diagnosis
preventive strategies – Failure to remocve local cause
– Insufficient potency
• Mucosal atrophy
• Delayed healing
• Systemic absorption
Corticosteroids
Steroid
- guidelines for topical GC
hydrocortisone sodium topical corticosteroid minor aphthae QDS - during ulcer attack
• Confident of clinical diagnosis Triamcinolone 0.1 % on as above minor/major aphthae apply QDS to dried arae
• Do not apply on lips and skin Betamethasone sodium as above minor/major aphthae TDS, dissolve in 10 mls of
12
F T ra n sf o F T ra n sf o
PD rm PD rm
Y Y
Y
Y
er
er
4/14/2011
ABB
ABB
y
y
bu
bu
2.0
2.0
to
to
re
re
he
he
k
k
lic
lic
C
C
w om w om
w
w
w. w.
A B B Y Y.c A B B Y Y.c
13